Extracorporeal Blood Purification in Sepsis and Sepsis-Related Acute Kidney Injury
- 1 January 2008
- journal article
- review article
- Published by S. Karger AG in Blood Purification
- Vol. 26 (1), 30-35
- https://doi.org/10.1159/000110560
Abstract
Sepsis-related acute kidney injury (AKI) is an important complicating feature of sepsis, and is associated with greater complexity of care and higher mortality. Until recently, AKI lacked a standard, widely accepted definition, rendering it difficult to compare previously published strategies to prevent, recognize and treat this entity. Recently, the RIFLE classification of AKI has been developed, and confirmed in observational studies to be associated with subsequent morbidity and mortality. The management of sepsis-related AKI is evolving with new basic discoveries and ongoing translational clinical research, and will likely include nephroprotective strategies to protect kidneys in patients at risk, early recognition and amelioration of renal damage and pharmacological interventions to minimize injury and promote recovery. Furthermore, extracorporeal blood purification (EBP) has an important role to play, not only in the replacement of certain aspects of renal organ function such as acid-base/electrolyte homeostasis and extracellular fluid volume, but also in an immunomodulatory fashion. As a therapy that has the potential to influence the course of disease in sepsis, EBP in sepsis and sepsis-related AKI is the subject of this review.Keywords
This publication has 38 references indexed in Scilit:
- Hemodialysis Membrane With a High-Molecular-Weight Cutoff and Cytokine Levels in Sepsis Complicated by Acute Renal Failure: A Phase 1 Randomized TrialAmerican Journal of Kidney Diseases, 2007
- Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic reviewCritical Care, 2007
- Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure*Critical Care Medicine, 2006
- Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effectsKidney International, 2006
- Bench-to-bedside review: Thrombocytopenia-associated multiple organ failure - a newly appreciated syndrome in the critically illCritical Care, 2006
- High-Volume Hemofiltration After Out-of-Hospital Cardiac ArrestJournal of the American College of Cardiology, 2005
- The effects of imidazoline agents on the aggregation of human plateletsJournal of Pharmacy and Pharmacology, 2004
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Tumor necrosis factor-α during continuous high-flux hemodialysis in sepsis with acute renal failureKidney International, 1999
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992